Skip to main content

2023

UCC spin-out CergenX awarded €6.7 million funding for their 'CergenX Wave device'

28 Nov 2023
Sean Griffin, CTO; Professor Geraldine Boylan, CSO; and Jason Mowles, CEO of CergenX

A new technology to screen newborns for brain injury has been awarded €6.7million in funding from the Disruptive Technology Innovation Fund (DTIF). The major investment will support scientists and engineers to advance brain health monitoring for newborn babies. The Irish Centre for Maternal and Child Health Research (INFANT) at University College Cork with UCC spin-out CergenX and Evervault were awarded €6.7million for the CergenX Wave Device, which will develop a novel platform to detect abnormal brain activity in infants soon after birth through an automated AI assessment.

UCC Innovation

Aistriú Nualaíocht

Room 2.44, Western Gateway Building, Western Road, Cork, Ireland, T12 XF62

Top